Primary Record
ITI-367
- In stock
- 4,746 g
- Purity
- 99.2 %
- CAS
- 288246-59-3
Compound Identifiers & Properties
- CAS
- 288246-59-3
- PubChem CID
- 589203
- SMILES
- COC1=CC=CC=C1C2=NOC(=O)N2C3=CC=CC(=C3)C(F)(F)F
- Canonical SMILES
- COc1ccccc1-c1noc(=O)n1-c1cccc(C(F)(F)F)c1
Names & Synonyms
- ITI-367
- UNII-GQW0N19G9O
- GQW0N19G9O
- AC1LBUGA
- RefChem:201332
- D08MLG
- Cni-H1194
- LQWTVDHYWXZDHM-UHFFFAOYSA-N
- SCHEMBL12289345
- SCHEMBL29588226
- CNI-H0294
- ITI-011
- PPI-367
- AIDS342593
- CNI-1194
- CID589203
- ITI-002, International Therapeutics Inc
- 1,2,4-Oxadiazol-5(4H)-one, 3-(2-methoxyphenyl)-4-(3-(trifluoromethyl)phenyl)-
- 288246-59-3
- Nuclear importation inhibition compounds (HIV-1)
- Q27279234
- Nuclear importation inhibition compounds (HIV-1), Presidio
- 3-(2-methoxyphenyl)-4-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-one
- Viral genome nuclear entry inhibitors (HIV-1 infection), ITI
- Viral genome nuclear entry inhibitors (HIV-1 infection), Presidio
- Viral genome nuclear entry inhibitors (HIV-1 infection), Presidion
- Nuclear importation inhibition compounds (HIV-1), Cytokine PharmaSciences
- 1,2,4-Oxadiazol-5(4H)-one, 3-(2-methoxyphenyl)-4-[3-(trifluoromethyl)phenyl]-
- 1,2,4-Oxadiazol-5(4H)-one, 4-(3-trifluoromethylphenyl)-3-(2-methoxyphenyl)-
- 3-(2-Methoxyphenyl)-4-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5(4H)-one #
- Viral genome nuclear entry inhibitors (HIV-1 infection), Cytokine PharmaSciences
- Viral genome nuclear entry inhibitors (HIV-1 infection), International Therapeutics
- 180741-00-8